Clowes Howard
SEC insider (Form 3/4/5 filer). CIK 0001806992. Director at CERENOME, INC. (CNSY). 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in HOUSTON, TX.
Companies Clowes Howard has filed insider reports for
- CERENOME, INC. (CNSY): Director
Clowes Howard
CIK: 0001806992
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERENOME, INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026CNSY
CERENOME, INC.
ExerciseDirect921 shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
ExerciseDirect922 shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectRestricted Stock Units
3.7K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
3.7K shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
297.8K shares- - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
40.1K shares- - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
PurchaseDirect5K shares at avg. $1.34$7K - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
3.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY CERENOME, INC. | Exercise | 921 | - | $0 | Direct |
| Jul 1, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Exercise | 922 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award Restricted Stock Units | 3,686 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 3,686 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 297,794 | - | - | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 40,122 | - | - | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Purchase | 5,000 | $1.34 | $6,681 | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 3,650 | - | - | Direct |
1-8 of 8 transactions